e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Immunology and cell biology of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-IgE and airway remodelling: Omalizumab affects reticular basement membrane thickness in severe persistent atopic asthma
A. M. Riccio, R. W. Dal Negro, L. De Ferrari, C. Micheletto, G. W. Canonica, C. Folli, A. Chiappori (Genoa, Bussolengo, Italy)
Source:
Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Session:
Immunology and cell biology of asthma and COPD
Session type:
Thematic Poster Session
Number:
3848
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. M. Riccio, R. W. Dal Negro, L. De Ferrari, C. Micheletto, G. W. Canonica, C. Folli, A. Chiappori (Genoa, Bussolengo, Italy). Anti-IgE and airway remodelling: Omalizumab affects reticular basement membrane thickness in severe persistent atopic asthma. Eur Respir J 2011; 38: Suppl. 55, 3848
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Noneosinophilic asthma in children: relation with airway remodelling
Source: Eur Respir J 2011; 38: 575-583
Year: 2011
Effects of a 12-month course with omalizumab on basement membrane thickness in severe persistent atopic asthma
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Effects of a 12-month course with omalizumab on nasal polyps and basement membrane in severe atopic asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Corticosteroid sensitivity, persistent airflow limitation and basement membrane thickening in children with asthma
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008
Reticular basement membrane (RBM) thickness, neutrophils and eosinophils in severe exacerbations of COPD and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Angiogenesis in the airway wall of atopic children without asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 599s
Year: 2006
Parameters associated with persistent airflow obstruction in chronic severe asthma
Source: Eur Respir J 2004; 24: 122-128
Year: 2004
Paracetamol and breakdown in epithelial barrier function in patients with asthma and atopic dermatitis
Source: Annual Congress 2010 - Risk factors for allergic diseases in children
Year: 2010
Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Osteopontin expression and relation to disease severity in human asthma
Source: Eur Respir J 2011; 37: 331
Year: 2011
Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Mepolizumab improves small airway function in severe eosinophilic asthma
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Basement membrane thickness, eosinophilic inflammation and urinary LTE
4
in patients with nasal polyps with or without bronchial asthma
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007
Increased arginase activity contributes to airway remodelling in chronic allergic asthma
Source: Eur Respir J 2011; 38: 318-328
Year: 2011
Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 4s
Year: 2001
Subclinical small-airway dysfunction precedes the development of asthma in children with allergic rhinitis
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Subepithelial basement membrane thickness in bronchial asthma assessed by bronchoscopy
Source: Eur Respir J 2005; 26: Suppl. 49, 118s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept